The Problem: Cancer Radiation Costs Are Breaking Families — And Wait Times Are Not Helping

Cancer does not wait for budgets. A 2023 report from the Singapore Cancer Society noted that out-of-pocket oncology costs remain one of the top three financial stressors for patients, even in a system with public subsidies. Proton therapy, while clinically superior for specific tumor types — pediatric cancers, skull-base tumors, certain head and neck malignancies — sits at the very top of that cost ladder. At SGD 100,000 on average, it is simply out of reach for many families who might benefit from it.

Then there is the capacity problem. Singapore’s proton facility at the National Cancer Centre Singapore opened with a single treatment room. A second is planned. But as of mid-2025, the wait for non-urgent proton cases can extend beyond what oncologists consider ideal for certain aggressive tumors. Patients with chordomas or chondrosarcomas, where proton therapy’s precision spares critical structures like the brainstem or optic nerves, do not have months to wait.

That is the hard reality. The technology exists. The clinical evidence supports it. But the intersection of cost and capacity creates a bottleneck that pushes patients to ask a question they never expected to ask: what if I leave the country for treatment?

Who We Are

We are not a hospital. We do not provide medical treatment, clinical diagnoses, or therapy recommendations. China Medical Services operates as a medical concierge and logistical coordination team — we bridge the gap between international patients and China’s top-tier hospitals. Our network spans 340+ top-ranked hospitals across 37 cities, representing the top 5% of China’s 35,000+ medical institutions as ranked by the Fudan University hospital ranking system and JCI accreditation standards. We handle case management: medical record translation, hospital selection based on your specific diagnosis, appointment coordination through official international department channels, bilingual medical companion services, and visa guidance. We do not promise outcomes. We promise process.

Why Proton Therapy in China Delivers Comparable Results at a Fraction of the Cost

The proton therapy cost Shanghai vs Singapore gap is not a reflection of quality differences. It reflects structural economics. Understanding why requires looking at three factors: clinical volume, technology infrastructure, and the cost structure of healthcare delivery in China.

Clinical Volume Drives Proficiency

SPHIC opened in 2015 as China’s first dedicated proton and heavy ion center. Since then, it has treated over 6,000 patients. That is not a projection. That is published data. The center treats approximately 900 to 1,000 patients annually across five treatment rooms. Compare this to most single-room proton facilities globally, where annual volumes hover between 150 and 300 patients.

Volume matters in radiation oncology. Treatment planning for proton therapy — defining beam angles, calculating dose distributions to sub-millimeter precision — is a skill that sharpens with repetition. SPHIC’s physics and dosimetry teams handle a caseload that few centers worldwide match. Published five-year survival data for stage I non-small cell lung cancer treated with heavy ion therapy at SPHIC shows rates of approximately 80%, consistent with Japanese and German heavy ion centers. For skull-base chordomas, local control rates at three years exceed 90% in their published series. These are not cherry-picked numbers. They appear in peer-reviewed journals including the International Journal of Radiation Oncology and Cancer Science.

Technology Infrastructure at Scale

SPHIC is not a single-gantry operation. The facility houses a synchrotron-based proton and heavy ion system — the same technology platform used at the Heidelberg Ion-Beam Therapy Center in Germany. It operates four treatment rooms: two fixed-beam rooms, one gantry room for proton therapy, and one heavy ion room. This multi-room configuration means the center can treat patients in parallel, reducing scheduling bottlenecks that plague single-room centers.

What does this mean for an international patient? Shorter wait times from consultation to treatment initiation. While independent verification of exact wait times requires case-by-case assessment, the multi-room infrastructure fundamentally changes throughput dynamics compared to a single-gantry facility.

Cost Structure Without Quality Compromise

This is the question every patient asks: how much cheaper is proton therapy in China, and does cheaper mean worse? The second part is easier to answer. It does not. The clinical outcomes published by SPHIC align with international benchmarks from centers in the United States, Japan, and Germany. The cost difference comes from structural factors that have nothing to do with treatment quality.

Chinese hospital labor costs are lower. That is an economic reality, not a quality indicator. A senior medical physicist in Shanghai earns less than their counterpart in Singapore or Boston, but their training — often including fellowships at proton centers in Japan, Europe, or the United States — is equivalent. Hospital construction costs, equipment amortization schedules, and operational overhead all run lower in China’s healthcare system. The synchrotron itself was developed through a collaboration between the Shanghai Institute of Applied Physics and SPHIC, reducing technology licensing costs that Western and Singaporean centers must pay to equipment vendors.

Put bluntly: the machine costs less to build and operate. The staff costs less to employ. The treatment room throughput is higher. Those three factors compound to produce a treatment price that is 60 to 70 percent below Singapore’s rates — without cutting corners on clinical protocols or safety standards.

Is Proton Therapy in China Safe for Cancer Patients?

The short answer is yes — with a caveat about choosing the right facility. Is proton therapy in China safe for cancer treatment? The evidence supports it, but the question deserves more than a one-word answer.

SPHIC operates under China’s National Medical Products Administration regulatory framework, which governs radiation therapy equipment calibration, safety protocols, and clinical practice standards. The center has treated patients referred from more than 20 countries, including Singapore, Australia, the United States, and multiple European nations. International patients are not an afterthought here. The facility maintains a dedicated international patient coordination office.

Safety in proton therapy comes down to three things: equipment precision, treatment planning quality, and clinical decision-making about which patients are appropriate candidates. SPHIC’s physics QA protocols require daily beam calibration checks — standard practice at any accredited proton center worldwide. Their treatment planning system uses the same software platforms (RayStation and Varian Eclipse) deployed at leading proton centers globally. The medical staff includes radiation oncologists who trained at institutions in Japan and Germany, where heavy ion therapy has a longer clinical track record.

One honest note: SPHIC is a Chinese public hospital. That means the patient experience — registration, billing, scheduling — runs through systems designed for domestic patients. English signage exists but is not universal. Nursing staff may have limited English proficiency. This is not a safety issue. It is a comfort and navigation issue. For patients who speak no Mandarin, navigating the hospital independently is genuinely difficult. That is not a criticism of the hospital. It is a description of reality.

The Best Proton Therapy Center in Shanghai for International Patients

When patients search for the best proton therapy center Shanghai international patients can access, SPHIC is the answer — but it is not the only answer. China’s proton therapy landscape is expanding, and understanding the options matters.

SPHIC, located in the Pudong district, remains the flagship. It offers both proton and heavy ion (carbon ion) therapy, which is a distinction worth understanding. Heavy ion therapy delivers a higher linear energy transfer than proton therapy, potentially offering superior biological effectiveness for radioresistant tumors like adenoid cystic carcinomas or certain sarcomas. Not every patient needs heavy ion therapy. For many indications, proton therapy alone is the appropriate modality. SPHIC’s ability to offer both under one roof is unusual globally and relevant for patients with complex or rare tumor types.

A newer option has emerged: the Hefei Ion Medical Center, which also operates a proton and heavy ion system. For certain indications, this center may offer shorter wait times. However, SPHIC’s longer clinical track record and established international patient workflow make it the more straightforward choice for first-time medical travelers to China.

For patients considering broader options, our oncology department rankings include hospitals with strong radiation oncology programs that may be relevant depending on tumor type and treatment goals. Proton therapy is one tool. Sometimes conventional IMRT at a top cancer center — at an even lower cost — is the more appropriate recommendation. A thorough case review should precede any facility decision.

How to Book Proton Therapy at SPHIC: The Process for Foreigners

Searching for how to book proton therapy Shanghai Proton and Heavy Ion Center leads many patients to assume they can email the hospital, send their scans, and receive a treatment slot. That is not how it works. Here is the actual process.

Step one: medical record preparation. SPHIC requires translated and summarized medical records including pathology reports, imaging studies (preferably DICOM format on CD or via secure upload), and a referral letter from the patient’s treating oncologist. Records in English are generally accepted, but Chinese translations of key documents accelerate the review process significantly.

Step two: the in-person consultation requirement. SPHIC, like all Chinese public hospitals, requires a face-to-face consultation before scheduling treatment. The radiation oncologist needs to examine the patient, review imaging with the physics team, and determine whether proton or heavy ion therapy is clinically appropriate. This cannot be done remotely. The patient must travel to Shanghai.

Step three: treatment planning. If the clinical team accepts the case, the patient undergoes a treatment planning CT scan at SPHIC. The physics team develops a customized beam plan, which typically takes one to two weeks. Only after plan approval does treatment begin.

Step four: treatment delivery. Proton therapy courses typically run five days per week for two to eight weeks, depending on the indication. The patient stays in Shanghai for the duration. SPHIC’s international office can recommend nearby accommodation, but they do not provide lodging directly.

This is where a proton therapy package for foreigners China becomes relevant. SPHIC does not sell “packages” in the commercial sense. What exists is a coordinated service bundle — appointment scheduling, record translation, visa support documentation, and bilingual accompaniment during consultations and treatment sessions. Independent travelers can piece this together themselves. Many find the coordination burden heavier than expected.

What You Need to Know Before Going Alone

We have guided patients through this process. We have also seen what happens when people try to navigate it solo. Here are the barriers that trip up even well-prepared international patients.

• Visa Requirements: Medical travelers to China require an S2 visa, specifically annotated for medical treatment purposes. The application requires an invitation letter from the treating hospital — which SPHIC will provide only after accepting the case. This creates a chicken-and-egg problem: you need the hospital’s acceptance to get the visa, but you need to be in China for the consultation that leads to acceptance. In practice, the initial consultation trip often happens on an L (tourist) visa, with the S2 obtained later. This is a gray area that makes patients uncomfortable — and immigration officials occasionally push back. Family members accompanying the patient also apply for S2 visas. Do not apply for an M visa; that is for commercial business and does not cover medical treatment.
• Payment Systems: SPHIC requires prepayment for treatment. International credit cards are not reliably accepted. The hospital’s payment system is designed for Chinese UnionPay cards and domestic bank transfers. International patients typically need to wire funds to the hospital’s account in advance or carry sufficient cash (in RMB) to cover treatment deposits. WeChat Pay and Alipay, while ubiquitous in China, cannot be easily linked to foreign bank accounts without a Chinese bank card. This is a genuinely frustrating friction point that catches many patients off guard.
• Language and Navigation: SPHIC’s registration desks, billing counters, and pharmacy operate in Mandarin. Signage includes some English, but staff outside the international office may not speak it. A patient arriving alone for daily treatment needs to navigate registration kiosks, queue for treatment room assignments, and communicate with radiation therapists — all in a language they likely do not speak. This is not impossible. Patients do it. But it adds stress to an already difficult medical experience.

How We Help You Navigate This

These barriers exist for structural reasons, not because anyone designed the system to exclude foreigners. Chinese public hospitals serve a domestic patient base of millions. International patients represent a tiny fraction of their volume. The systems are optimized for the majority. Our job is to bridge that gap.

We start with a case review. You send us your medical records. We translate and summarize them for the target hospital’s international department. We coordinate the initial consultation appointment — not by promising a specific doctor or date, but by working through the hospital’s official scheduling channel. If the appointment cannot be secured, our coordination fee for that service is refunded in full. That is our policy.

When you arrive in Shanghai, a bilingual medical companion meets you at the hospital. This person handles registration, payment processing, queue management, and real-time translation during your consultation with the radiation oncologist. They do not provide medical advice. They ensure you understand what the doctor is saying and that the doctor understands your questions. During the treatment course, the companion can accompany you to daily sessions as needed, handling the ground-level logistics so you can focus on treatment and recovery.

We also handle the visa support documentation — ensuring the hospital provides the correct invitation letter format for the S2 application — and can advise on accommodation near SPHIC in Pudong. Our airport transfer service runs $200 round-trip. Bilingual companion services start from $200 per day. Full coordination for a proton therapy course, including record preparation, appointment scheduling, companion services, and logistical support, typically falls in the range of $3,000 to $6,000 depending on treatment duration and complexity. Every dollar of that is a coordination fee. Hospital treatment charges are separate and paid directly to SPHIC.

For patients who want to start with a remote evaluation before committing to travel, we can arrange a video consultation with a radiation oncologist familiar with SPHIC’s referral criteria, typically at $300 to $500. If that consultation leads to in-person treatment coordination within 90 days, the consultation fee is credited in full toward the coordination service. It is a one-time credit — it never applies to hospital treatment charges — but it means the initial evaluation costs you nothing if you move forward.

Explore our Shanghai hospital network for a broader view of treatment options in the city, or visit our patient coordination page to understand how the full service works.

Frequently Asked Questions